Machinify is an AI-powered healthcare intelligence platform that automates and optimizes the healthcare claims lifecycle, from prior authorization to final payment, reducing administrative costs and improving accuracy for payers, providers, and patients.[1][2][3][4] The company builds a cloud-based software suite powered by machine learning, natural language processing (NLP), optical character recognition (OCR), and large language models (LLMs), trained on billions of claims and millions of medical records to handle complex medical coding, policy validation, and payment integrity.[2][3][5][6] It serves major U.S. health insurance payers—including four of the top 10—covering about 52 million lives and reviewing $200 billion in claims annually, delivering over $4 billion in client savings each year through tools like Machinify Auth (80%+ auto-approval rates), claim reviews, and subrogation.[2][3][5] Formerly known as Rawlings, Machinify demonstrates strong growth momentum with production deployments at top payers, a rebrand emphasizing AI innovation, and a partial asset sale to Evolent in 2024 for utilization management tech.[3][7][8]
Machinify was founded in 2016 in Palo Alto, California, by Prasanna Ganesan, a serial entrepreneur with expertise in AI and healthcare data, aiming to tackle waste in the multi-trillion-dollar U.S. healthcare claims process using AI.[1][2][5][7] The idea emerged from recognizing the inefficiency of manual claims handling, leading to the development of an AI platform for automation.[5][6] Early traction built on Ganesan's vision, evolving from Rawlings—a legacy payment integrity firm backed by New Mountain Capital—through acquisitions and rebranding to integrate AI across the payment continuum.[3][8] Pivotal moments include launching a comprehensive app suite in March 2024 for end-to-end claims automation and selling AI utilization management assets to Evolent in June 2024, allowing focus on core strengths while partnering for broader impact.[2][7]
Machinify stands out in healthcare AI through these key strengths:
Machinify rides the AI transformation in healthcare administration, addressing $200B+ in annual U.S. administrative waste amid rising claims volumes and payer pressures for efficiency.[2][5] Timing is ideal with advances in LLMs, NLP, and generative AI enabling "AI-first" processes that manual systems can't match, fueled by market forces like value-based care, regulatory scrutiny on payments, and payer consolidation.[3][6][7] By partnering with top insurers and influencing standards for transparent AI (e.g., bias checks, explainability), Machinify accelerates ecosystem-wide shifts toward automated, cost-effective payments, benefiting providers via faster approvals and patients through lower friction and costs.[2][4][8]
Machinify is positioned for expansion by deepening AI integrations post-Evolent deal, targeting more specialties beyond oncology/cardiology via SaaS models and hybrid delivery.[4][7] Trends like multimodal AI, real-time data unification, and regulatory pushes for AI safety will shape its path, potentially scaling to global payers and new verticals like provider-side billing.[1][6] Its influence may evolve from niche innovator to industry standard-setter, further reducing healthcare's administrative burden—echoing its founding mission to leverage data at scale for economic transformation.[2][7]
Machinify has raised $10.0M in total across 1 funding round.
Machinify's investors include Top Harvest Capital.
Machinify has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in October 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2018 | $10.0M Series A | Top Harvest Capital |
